Quality biology support

Concept discussion & design

Concept discussion & design

Biology, modality & technology validation

Target validation, prioritization and discovery

Assay cascade & target engagement

Drug – disease translational validation

Molecular indication & population selection

Path to drug & tech development

Path to clinic

Discover all our
accelerator solutions

Therapeutic relevance assessment: critical scientific gap analysis & advice

PoC validation: biology, modality or technology

Program prioritization for drug & tech development

Assay development for drug development & translational research

Molecular indication selection & patient stratification

Discover all our
accelerator solutions

Therapeutic relevance assessment: critical scientific gap analysis & advice

PoC validation: biology, modality or technology

Program prioritization for drug & tech development

Assay development for drug development & translational research

Molecular indication selection & patient stratification

Discover all our
accelerator solutions

Therapeutic relevance assessment: critical scientific gap analysis & advice

PoC validation: biology, modality or technology

Program prioritization for drug & tech development

Assay development for drug development & translational research

Molecular indication selection & patient stratification

Discover all our
accelerator solutions

Therapeutic relevance assessment: critical scientific gap analysis & advice

PoC validation: biology, modality or technology

Program prioritization for drug & tech development

Assay development for drug development & translational research

Molecular indication selection & patient stratification

Therapeutic relevance assessment: critical scientific gap analysis & advice

Get in touch

Discovery Studio provides a multidisciplinary point of view on your biology-specific research plan, value inflection points and key data. We focus on all scientific factors contributing to Therapeutic relevance, either in PoC stage working towards product dev or in translation-to-clinic stage, supporting clinical positioning.
In particular need-to-have versus nice-to-have translational and computational experiments are critically defined and advised on.
Discovery Studio provides an interplay of computational and wetlab biology support, specifically tailored to drive your project-specific validation.

We can handle a wide spectrum of projects, ranging from target validation over therapeutic modality support up to technology platform pilot validation. Importantly, we are set up to offer solutions maximally adapted to your project-specific challenges.

PoC validation:
biology, target,
modality or technology

Get in touch

Program prioritization for drug & tech development

Get in touch

Discovery Studio applies its biology approaches and tools towards evidence-based decision-making during the multiple selection and prioritization challenges medical companies classically face.


Early on we support target prioritization for initiation of drug development, thereby defining further company focus. At a later stage, we drive drug development program (de)prioritization based on MoA differentiation and/or match with disease (subtype) MoA.

Discovery Studio provides cellular and molecular assay development focused on multiparametric measurement quality, sensitivity and, if needed, industrialization readiness.

When focusing on drug development we build biology assay cascades allowing drug optimization, whereas when translational support is needed, we develop translational assays centered on the use of primary cell types, patient cell sources and mixed cultures closely mimicking human disease processes.

Assay development for drug development & translational research

Get in touch

Molecular indication selection & patient stratification

Get in touch

Discovery Studio uses deep molecular signatures to identify maximal MoA overlap between clinical candidate drugs – tech and disease mechanisms.


With a mix of computational power and strong bioinformatics knowhow, we support molecular selection of clinical indication and patient stratification.

What we do

Independent biotech accelerator, cellular biology-centric & therapeutic evidence-based.

Our capabilities

Bioinformatics, omics & cellular wetlab, senior support, research plan design.

Our facilities

Accelerate your promising therapies to patients in need.

Concept discussion & design